Skip to main
BNTC

BNTC Earnings Dates & Reports

BNTC Most Recent Earnings

Report Date
Period EndingQ3 2026
Est. EPS-$0.27
Actual EPS-$0.24
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

BNTC Earnings per Share (EPS) History

Signup for full access
Browse free

BNTC Latest Earnings

The value each BNTC share was expected to gain vs. the value each share gained.

BNTC reported its most recent earnings on for Q3 2026, posting earnings per share (EPS) of -$0.24. This exceeded analysts' expectations of -$0.27 by 11.11%, marking a Beat.

For comparison, Benitec Biopharma Limited Sponsored ADR reported EPS of -$0.24 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.34.

BNTC Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2026
-$0.34
Q3 2026
-$0.27-$0.24-11.11%
Q2 2026
-$0.23-$0.26+13.04%
Q1 2026
-$0.33-$0.22-33.33%
Q4 2025
-$0.30-$0.42+40.00%
View all

BNTC Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Benitec Biopharma Limited Sponsored ADR’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

BNTC Earnings FAQs

BNTC last reported earnings on May 14, 2026 for Q3 2026, posting an EPS of -$0.24, which Beat the estimate of -$0.27 by 11.11%.

For Q3 2026, BNTC reported an EPS of -$0.24, exceeding analysts' estimate of -$0.27 by 11.11%.

For Q3 2026, BNTC Beat expectations with an actual EPS of -$0.24 vs. an estimated EPS of -$0.27.

Following the last earnings report on May 14, 2026, BNTC's stock price moved — from — to —.

The next BNTC earnings call is scheduled for Sep. 21, 2026, where executives will discuss financial results and outlook.

Benitec Biopharma Limited Sponsored ADR (BNTC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.